Compare Mounjaro vs Wegovy Doses for Effective Weight Loss
Understanding Mounjaro vs Wegovy Doses for Prescription Weight Loss
When comparing Mounjaro vs Wegovy doses for prescription weight loss, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist targeting two appetite-regulating pathways simultaneously. Both prescription-only medicines require gradual dose escalation to minimise side effects and optimise tolerability. Wegovy follows a structured 16-week escalation from 0.25mg to the maintenance dose of 2.4mg, whilst Mounjaro escalates from 2.5mg to a maximum of 15mg over 12-16 weeks.
The dosing frequency remains consistent for both treatments—once weekly subcutaneous injections using pre-filled pens. However, the dose escalation timelines and maximum doses differ significantly when evaluating Mounjaro vs Wegovy doses for your weight management goals. Wegovy's maintenance dose of 2.4mg has been extensively studied in the STEP clinical trial programme, demonstrating an average weight loss of approximately 15% at 68 weeks when used alongside a reduced-calorie diet and increased physical activity. Mounjaro's higher maximum dose of 15mg reflects its dual mechanism, requiring different dosing considerations that your prescriber will evaluate during clinical assessment.
Wegovy Pricing and Mounjaro vs Wegovy Dose Value Comparison
Understanding the cost implications when comparing Mounjaro vs Wegovy doses helps inform your prescription weight loss investment. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenient dose progression, such as the Intro Duo (0.25mg and 0.5mg) for £169.99, supporting your initial dose escalation journey. New customers benefit from code FIRST40, whilst returning customers use DOSE25, both applied at checkout to reach these competitive prices.
When evaluating Mounjaro vs Wegovy doses from a value perspective, consider the different escalation timelines and maintenance requirements. Wegovy's 16-week dose escalation to maintenance means approximately four months of graduated dosing before reaching your target therapeutic dose. Our Step-Up bundles, like the Intro Trio (0.25mg, 0.5mg, and 1mg) for £299.99, provide three months of progressive dosing in one convenient order. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, ensuring consistent access once you've reached your optimal Wegovy dose through our GPhC-registered pharmacy service.
Clinical Evidence Comparing Mounjaro vs Wegovy Dose Effectiveness
The clinical evidence supporting Mounjaro vs Wegovy doses comes from separate trial programmes with different patient populations and study designs. Wegovy's efficacy was demonstrated in the STEP trial series, with STEP 1 showing participants achieved an average weight loss of approximately 15% at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial confirmed sustained weight loss of approximately 15.2% at two years, supporting long-term effectiveness when used alongside lifestyle modifications.
Mounjaro's clinical evidence derives from the SURMOUNT trial programme, demonstrating its dual GIP/GLP-1 mechanism across different dose levels. However, direct head-to-head comparisons between Mounjaro vs Wegovy doses aren't available due to different trial populations, endpoints, and methodologies. Both treatments showed significant weight loss compared to placebo in their respective studies, with effectiveness dependent on adherence to prescribed doses, dietary modifications, and physical activity increases as outlined in their licensed indications.
How Wegovy Works in Mounjaro vs Wegovy Dose Comparisons
Understanding how Wegovy functions helps clarify the Mounjaro vs Wegovy dose decision for your prescription weight loss journey. Wegovy's active ingredient, semaglutide, is a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a hormone naturally released by your intestines after eating. This mechanism reduces appetite by acting on brain appetite centres, promotes feelings of fullness after smaller meals, and may reduce food cravings throughout the day. The once-weekly injection maintains consistent blood levels, providing sustained appetite regulation between doses. Wegovy's dose escalation schedule allows your body to gradually adapt to increased semaglutide levels, optimising tolerance whilst building therapeutic effectiveness over the 16-week escalation period to the 2.4mg maintenance dose.
Ordering Process for Mounjaro vs Wegovy Dose Assessment
Accessing either treatment in the Mounjaro vs Wegovy doses comparison begins with EverydayMeds' streamlined 3-minute online clinical assessment, designed to evaluate your suitability for prescription weight loss medication. Our licensed prescribers review your medical history, current medications, weight management goals, and any contraindications within standard 3 working days, or 24 hours with express service. Once approved, your chosen treatment ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. The assessment considers your BMI (≥30, or ≥27 with weight-related comorbidities), previous weight loss attempts, and individual factors that influence the Mounjaro vs Wegovy dose recommendation. Our GPhC-registered pharmacy service (#9012878) ensures all prescriptions meet regulatory requirements whilst providing ongoing clinical support throughout your weight management journey.
Storage and Practical Considerations for Mounjaro vs Wegovy Doses
Practical storage requirements may influence your Mounjaro vs Wegovy dose preference, particularly if you travel frequently or have limited refrigeration access. Wegovy requires refrigeration at 2-8°C before first use but offers a significant advantage with 6 weeks of room temperature storage below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Both treatments use pre-filled injection pens—Wegovy's FlexTouch pen system provides user-friendly administration with clear dose indicators and safety features. The weekly injection schedule for both options means fewer injections compared to daily medications, improving adherence and convenience. Dose escalation protocols differ between treatments, with Wegovy's 4-week intervals at each dose level allowing thorough tolerance assessment before progression, whilst Mounjaro follows its own manufacturer-specified escalation timeline that your prescriber will explain during consultation.
Personalised Mounjaro vs Wegovy Dose Selection for Prescription Weight Loss Success
Determining the optimal choice in Mounjaro vs Wegovy doses requires individualised assessment of your medical profile, weight loss history, and lifestyle factors. Your prescriber evaluates factors such as previous GLP-1 agonist experience, gastrointestinal tolerance, concurrent medications, and specific weight management goals when recommending between these prescription weight loss options. Some patients may benefit from Wegovy's single-pathway GLP-1 mechanism, particularly if they have experience with incretin-based therapies, whilst others might be candidates for Mounjaro's dual mechanism approach.
The Mounjaro vs Wegovy dose decision also considers practical factors such as injection confidence, storage capabilities, and long-term treatment adherence preferences. Both treatments require commitment to lifestyle modifications including reduced-calorie diet and increased physical activity, as specified in their licensed indications. EverydayMeds' clinical team provides ongoing support to monitor your response to whichever treatment is prescribed, with options to adjust or switch medications if clinically appropriate under proper medical supervision.
Start Your Prescription Weight Loss Journey with Expert Dose Guidance
Both Wegovy and Mounjaro are available from EverydayMeds, and our experienced prescribers can help determine which treatment and dosing schedule best suits your individual weight management needs. Begin with our confidential online assessment to discuss your Mounjaro vs Wegovy dose options, supported by our GPhC-registered pharmacy service (#9012878) and competitive pricing from £79.99. Use discount code FIRST40 for new customers or DOSE25 for returning customers, both applied at checkout for immediate savings. Our clinical team provides comprehensive guidance on dose escalation, storage requirements, and ongoing monitoring to optimise your prescription weight loss results. Visit https://everydaymeds.co.uk/collections/wegovy to start your assessment today and take the first step towards clinically-supported weight management with expert prescriber guidance.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
